Virtu Financial’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Virtu Financial’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-56,487	Closed	-$8K	–	2326
2023 Q4	$8K	Buy	56,487 +44,185	+359%	+$6.86K	﹤0.01%	1434
2023 Q3	$2K	Sell	12,302 -11,728	-49%	-$14.6K	﹤0.01%	1183
2023 Q2	$75K	Buy	24,030 +3,835	+19%	+$11.4K	0.01%	1089
2023 Q1	$52K	Buy	+20,195	New	+$41.7K	0.01%	1089
2022 Q3	–	Sell	-14,491	Closed	-$19K	–	2370
2022 Q2	$19K	Buy	14,491 +2,030	+16%	+$3.48K	﹤0.01%	1346
2022 Q1	$30K	Buy	+12,461	New	+$32.5K	﹤0.01%	1237

Other funds holding GRTX

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial's GRTX Position: Q1 2024 in Review

Virtu Financial sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q1 2024, closing a stake of 56,487 shares — an estimated $8K sold.

Virtu Financial first reported a position in GRTX in Q1 2022 and held it in 6 quarters. The position peaked at $75K in Q2 2023. 36 funds tracked by Wall St. Rank hold GRTX as of Q1 2024.

Virtu Financial reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Virtu Financial sold 56,487 Galera Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $8K.
Virtu Financial first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
Virtu Financial's Galera Therapeutics, Inc. Common Stock position peaked at $75K in Q2 2023.
36 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.